Your browser doesn't support javascript.
loading
Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes.
Heller, Simon; Raposo, João Filipe; Tofé, Santiago; Hanif, Wasim; Schroner, Zbynek; Down, Su; Blevins, Thomas.
Affiliation
  • Heller S; Department of Oncology and Metabolism, University of Sheffield School of Medicine, Sheffield, U.K.
  • Raposo JF; APDP-Diabetes Portugal and Nova Medical School, Lisbon, Portugal.
  • Tofé S; Endocrinology Department, University Hospital Son Espases and University of the Balearic Islands School of Medicine, Palma de Mallorca, Spain.
  • Hanif W; Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K.
  • Schroner Z; Faculty of Medicine, Slovak Medical University, Kosice, Slovakia.
  • Down S; Somerset Foundation Trust, Taunton, Somerset, U.K.
  • Blevins T; Texas Diabetes and Endocrinology, Austin, TX.
Clin Diabetes ; 41(2): 154-162, 2023.
Article in En | MEDLINE | ID: mdl-37092154
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Diabetes Year: 2023 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Diabetes Year: 2023 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos